Clicks to sell stake in Unicorn Pharmaceuticals

Following a Constitutional Court ruling, Clicks Group plans to sell its shareholding in Unicorn Pharmaceuticals, enabling new pharmacy license applications.

This article is for Health Matters subscribers

Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

SubscribeLog in

More from Health Matters

8 October 2026

Cancer in South Africa is rising, with deaths forecast to nearly double by 2050. Learn what ageing, smoking and urbanisation mean for care.

8 October 2026

Hospitals are investing in infection prevention and control as antimicrobial resistance rises, but experts say gaps remain.

8 October 2026

Experts say South Africa should track medicine shortages by whether patients get full treatment on time, not by stock figures alone.